Who
Nancy T. Chang
Director and 10% owner
Company insider
Files Form 4 as: Director and 10% owner, Galera Therapeutics; Director, W&T Offshore; Director, Immix Biopharma; Director, Sciclone Pharmaceuticals; Director, Charles River Laboratories International; Director and 10% owner, Tanox.
In numbers
- Trades disclosed
- 100
- Buys
- 2
- Sells
- 26
- Bought
- $685K
- Sold
- $3.0M
- Companies
- 6
- Companies where not an officer
- 6
- First trade
- 14 Apr 2005
- Last trade
- 3 Aug 2026
- Last filed
- 5 Aug 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 3 Aug 2026filed 5 Aug 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code D | —47,434 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —480 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code D | —480 | filing |
| 3 Aug 2026filed 5 Aug 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code D | —47,434 | filing |
| 15 Jul 2026filed 16 Jul 2026 | WTI W&T OffshoreOil & Gas E&P | SEC FORM 4 Sold | $199K60,000 at $3.31 | filing |
| 15 Jul 2026filed 16 Jul 2026 | WTI W&T OffshoreOil & Gas E&P | SEC FORM 4 Sold | $199K60,000 at $3.31 | filing |
| 3 Jun 2026filed 5 Jun 2026 | WTI W&T OffshoreOil & Gas E&P | SEC FORM 4 Code M | —103,448 | filing |
| 3 Jun 2026filed 5 Jun 2026 | WTI W&T Offshoreoption or derivative · Oil & Gas E&P | SEC FORM 4 Code A | —35,972 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | WTI W&T Offshoreoption or derivative · Oil & Gas E&P | SEC FORM 4 Code M | —103,448 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | WTI W&T Offshoreoption or derivative · Oil & Gas E&P | SEC FORM 4 Code A | —35,972 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | WTI W&T Offshoreoption or derivative · Oil & Gas E&P | SEC FORM 4 Code M | —103,448 at $0.00 | filing |
| 3 Jun 2026filed 5 Jun 2026 | WTI W&T OffshoreOil & Gas E&P | SEC FORM 4 Code M | —103,448 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 22 May 2026filed 29 May 2026 | IMMX Immix BiopharmaBiotechnology | SEC FORM 4 Code A | —6,250 at $0.00 | filing |
| 15 May 2026filed 5 Aug 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code C | —661,309 | filing |
| 15 May 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —661.309 at $0.00 | filing |
| 15 May 2026filed 5 Aug 2026 | Galera Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code C | —661.31 at $0.00 | filing |
| 15 May 2026filed 5 Aug 2026 | Galera TherapeuticsBiotechnology | SEC FORM 4 Code C | —661,309 | filing |
News
W&T Offshore (WTI) Expected to Release Earnings on ThursdayWTI · dailypolitical.com · 22 Oct 2026
0 headlines in the last 90 days name Nancy T. Chang; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.